Editor’s note: The Parkinson’s News Today team is providing in-depth coverage of the 2021 Virtual AAN Annual Meeting, April 17–22. Go here to read the latest stories from the conference. UCB’s experimental oral therapy UCB0599 was generally well tolerated in people with mild to moderate Parkinson’s disease…
News
A newly opened Phase 2 clinical trial is evaluating adult stem cells as a potentially disease-modifying treatment for Parkinson’s, building on an earlier study, thought to be the first of its kind, that found a single infusion of these cells safe and well tolerated by patients. This study will use…
Editor’s note: The Parkinson’s News Today team is providing in-depth coverage of the 2021 Virtual AAN Annual Meeting, April 17–22. Go here to read the latest stories from the conference. Long-term treatment with Duodopa (levodopa-carbidopa intestinal gel) safely and effectively lessens motor and non-motor symptoms and improves quality of life…
Editor’s note: The Parkinson’s News Today team is providing in-depth coverage of the 2021 Virtual AAN Annual Meeting, April 17–22. Go here to read the latest stories from the conference. In two clinical studies, Kynmobi (apomorphine hydrochloride) was associated with greater and faster motor improvement than was levodopa among…
Editor’s note: The Parkinson’s News Today team is providing in-depth coverage of the 2021 Virtual AAN Annual Meeting, April 17–22. Go here to read the latest stories from the conference. Carbidopa/levodopa enteral suspension (CLES) provided long-term, sustained, and clinically meaningful reductions in “off” time for people with Parkinson’s disease, according…
Editor’s note: The Parkinson’s News Today team is providing in-depth coverage of the 2021 Virtual AAN Annual Meeting, April 17–22. Go here to read the latest stories from the conference. Tasigna (nilotinib), an approved leukemia medication, was seen to be safe and tolerable at high…
PhotoPharmics plans to open, possibly this summer, a pivotal Phase 3 clinical trial of its light-based and noninvasive Celeste device in treating Parkinson’s symptoms, for use by patients at home and with trial goals evaluated using telemedicine. A particular company goal for this device, PhotoPharmics also announced, is reaching underserved patients…
Editor’s note: The Parkinson’s News Today team is providing in-depth coverage of the 2021 Virtual AAN Annual Meeting, April 17–22. Go here to read the latest stories from the conference. The investigational medication SEP-363856 might ease symptoms of Parkinson’s disease psychosis, according to data from a…
MedRhythms is launching a clinical trial of its experimental digital therapy MR-005, which seeks to use sensors, music, and software to improve walking ability in people with Parkinson’s disease and other neurological disorders. The technology, which received a patent in the United States last year, works by…
Zarela Martinez, a celebrity chef with Parkinson’s disease (PD), has partnered with Acorda Therapeutics to create a video series aimed at helping people live well with the progressive neurodegenerative disorder. Release of the series, called “A Taste for Life with Zarela,” coincides with Parkinson’s Awareness Month, observed each April.
Recent Posts
- I wish I could take my husband’s pain away
- Toxic protein clumps damage brain blood vessels in Parkinson’s: Study
- Support concerns lead women with Parkinson’s to shun DBS: Study
- Words of wisdom for living well with Parkinson’s disease
- AAN 2026: Tavapadon helps delay levodopa start in early Parkinson’s